Squarepoint Ops LLC - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 218 filers reported holding REATA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.9%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$2,161,077
-36.3%
23,769
-73.4%
0.01%
-30.8%
Q4 2022$3,391,899
+227.4%
89,284
+116.6%
0.01%
+160.0%
Q3 2022$1,036,000
+47.2%
41,219
+77.9%
0.01%
+25.0%
Q2 2022$704,000
-64.2%
23,175
-69.0%
0.00%
-20.0%
Q4 2021$1,969,000
-2.1%
74,679
+273.5%
0.01%
-16.7%
Q3 2021$2,012,000
+104.7%
19,996
+188.0%
0.01%
+50.0%
Q2 2021$983,000
+29.5%
6,944
-8.8%
0.00%0.0%
Q1 2021$759,000
+145.6%
7,615
+204.2%
0.00%
+100.0%
Q4 2020$309,000
-70.2%
2,503
-62.3%
0.00%
-88.2%
Q2 2020$1,037,000
-74.3%
6,648
-66.3%
0.02%
-29.2%
Q4 2019$4,038,000
+1150.2%
19,751
+391.4%
0.02%
+700.0%
Q3 2019$323,000
-54.4%
4,019
-46.4%
0.00%
-57.1%
Q2 2019$708,000
-13.6%
7,500
-21.7%
0.01%
-22.2%
Q1 2019$819,000
-29.2%
9,580
-53.5%
0.01%
-30.8%
Q4 2018$1,156,000
+13.6%
20,605
+65.5%
0.01%
+8.3%
Q3 2018$1,018,000
+50.4%
12,450
-62.3%
0.01%
+9.1%
Q1 2018$677,000
+54.9%
33,000
+113.8%
0.01%
+37.5%
Q4 2017$437,00015,4340.01%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
CPMG Inc 2,896,901$291,457,00032.14%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 46,646$4,693,0005.31%
Ikarian Capital, LLC 471,400$47,423,0003.34%
Duquesne Family Office 695,033$69,927,0002.27%
Camber Capital Management LP 685,000$68,918,0002.12%
LBJ Family Wealth Advisors, Ltd. 30,359$3,054,0001.82%
MADDEN SECURITIES Corp 33,127$3,333,0001.80%
Biondo Investment Advisors, LLC 104,120$10,475,0001.80%
Tolleson Wealth Management, Inc. 60,750$6,112,0001.73%
Keel Point, LLC 97,074$9,767,0001.26%
View complete list of REATA PHARMACEUTICALS INC shareholders